I address that in my brief in places where I think both the act as it stands is adequate to achieve precautionary outcomes and in places where the implementation of the act has fallen short. I also acknowledge places where I think the departmental officials doing the screening assessments right now are going above and beyond what's required in CEPA to try to account for, as an example, endocrine disrupting effects in a couple of the assessments.
I think it's both. We need new and stronger provisions that will give precautionary outcomes, and we have to make sure that the implementation follows those provisions more tightly than it has in the past.